- Home
- BQ vs QNRX Comparison
BQ vs QNRX Comparison
Compare BQ & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- QNRX
- Stock Information
- Founded
- BQ 2008
- QNRX 2018
- Country
- BQ China
- QNRX United States
- Employees
- BQ N/A
- QNRX N/A
- Industry
- BQ Other Specialty Stores
- QNRX Medical/Dental Instruments
- Sector
- BQ Consumer Discretionary
- QNRX Health Care
- Exchange
- BQ Nasdaq
- QNRX Nasdaq
- Market Cap
- BQ 2.5M
- QNRX 2.5M
- IPO Year
- BQ 2020
- QNRX N/A
- Fundamental
- Price
- BQ $2.12
- QNRX $0.29
- Analyst Decision
- BQ
- QNRX
- Analyst Count
- BQ 0
- QNRX 0
- Target Price
- BQ N/A
- QNRX N/A
- AVG Volume (30 Days)
- BQ 11.9K
- QNRX 10.6M
- Earning Date
- BQ 04-08-2025
- QNRX 03-13-2025
- Dividend Yield
- BQ N/A
- QNRX N/A
- EPS Growth
- BQ N/A
- QNRX N/A
- EPS
- BQ N/A
- QNRX N/A
- Revenue
- BQ $81,208,354.00
- QNRX N/A
- Revenue This Year
- BQ N/A
- QNRX N/A
- Revenue Next Year
- BQ N/A
- QNRX N/A
- P/E Ratio
- BQ N/A
- QNRX N/A
- Revenue Growth
- BQ N/A
- QNRX N/A
- 52 Week Low
- BQ $2.01
- QNRX $0.21
- 52 Week High
- BQ $7.40
- QNRX $1.57
- Technical
- Relative Strength Index (RSI)
- BQ 33.54
- QNRX 49.51
- Support Level
- BQ $2.01
- QNRX $0.21
- Resistance Level
- BQ $2.62
- QNRX $0.32
- Average True Range (ATR)
- BQ 0.14
- QNRX 0.03
- MACD
- BQ 0.00
- QNRX -0.00
- Stochastic Oscillator
- BQ 16.18
- QNRX 38.70
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.